MethylDetect Looks to Leverage High-Resolution Melt Tech for Oncology Assay Development full story at: https://www.genomeweb.com/pcr/methyldetect-looks-leverage-high-resolution-melt-tech-oncology-assay-development?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Fri%20PM%202019-01-25&utm_term=GW%20Daily%20News%20Bulletin#.XEwyFy2ZMc0 Category: FeaturedBy MethylDetectJanuary 26, 2019 Author: MethylDetect Post navigationPreviousPrevious post:Ampliqon A/S and Methyldetect ApS inked a collaboration agreementNextNext post:Our assay helps to identify cancer predisposition – Lynch SyndromeRelated postsProud to be one of the finalists of SCALE-UP Denmark National Finale 2018September 29, 2018MethylDetect ApS featured in September profile of the month at BIOPEOPLESeptember 25, 2018Visit us at 4BIO Summit 2018, 27th-28th Nov 2018, Rotterdam, NetherlandsAugust 29, 2018We have qualified to Accelerace program – Europe’s leading seen accelerator September 30, 2017Talk To MethylDetect At Danish Ip Fair On May 9thAugust 25, 2017
